Betsy Brotherton

Efficacy and safety of a fixed‐dose combination of dutasteride and tamsulosin treatment ( <scp>D</scp> uodart ^® ) compared with watchful waiting with initiation of tamsulosin therapy if symptoms do not improve, both provided with lifestyle advice, in the management of treatment‐naïve men with moderately symptomatic benign prostatic hyperplasia: 2‐year <scp>CONDUCT</scp> study results

Claus G. Roehrborn, Igor Oyarzabal Perez, Erik P.M. Roos et al. · British Journal of Urology · 2015 · 94 citations · Full text

Medicine, Pharmacotherapy, Urology +12

Long‐term safety and efficacy of dutasteride in the treatment of male patients with androgenetic alopecia

Yuichiro Tsunemi, Ryokichi Irisawa, Hiromu Yoshiie et al. · The Journal of Dermatology · 2016 · 60 citations

Medicine, Pharmacology, Pharmacotherapy +17

Influence of baseline variables on changes in <scp>I</scp> nternational <scp>P</scp> rostate <scp>S</scp> ymptom <scp>S</scp> core after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4‐year results of the <scp>CombAT</scp> study

Claus G. Roehrborn, Jack Barkin, Andrea Tubaro et al. · British Journal of Urology · 2013 · 55 citations

Medicine, Pharmacotherapy, Urology +14

Prospective randomized study of sexual function in men taking dutasteride for the treatment of androgenetic alopecia

Tsen‐Fang Tsai, Gwang Seong Choi, Beom Joon Kim et al. · The Journal of Dermatology · 2018 · 18 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Can we use baseline characteristics to assess which men with moderately symptomatic benign prostatic hyperplasia at risk of progression will benefit from treatment? A post hoc analysis of data from the 2-year CONDUCT study

Claus G. Roehrborn, Igor Oyarzabal Perez, Erik P.M. Roos et al. · World Journal of Urology · 2016 · 14 citations · Full text

Medicine, Pharmacotherapy, Urology +10